Wi‑Fi-frequency radiation and SARS-CoV-2 spike protein: the immune-system question FDA cannot ignore
A new 2026 study found that non-heating 2.45 GHz radiofrequency fields altered how immune cells handled bacterial stress and SARS-CoV-2 spike protein — changing mitochondria, lysosomes, nitric oxide signaling, and cell-death pathways.
The paper in the International Journal of Molecular Sciences adds a major new piece to the wireless radiation debate. Researchers exposed RAW 264.7 macrophages — immune cells commonly used in laboratory studies — to 2.45 GHz radiofrequency fields, the same general frequency range used by many Wi‑Fi, Bluetooth, and other 2.4 GHz wireless devices. The exposures were described as subthermal, meaning the study was designed to examine biological effects not explained by tissue heating. The cells were then challenged with LPS, a bacterial inflammatory trigger, and/or SARS-CoV-2 spike protein.
The results were not subtle at the cellular level. The researchers reported that the combination of RF exposure and infection-related stressors reprogrammed the interaction between mitochondria, lysosomes, nitric oxide signaling, and cell death in macrophages. In plain English: the radiation did not merely “sit there” harmlessly in the background. Under immune stress conditions, it changed how immune cells managed energy production, cellular cleanup, inflammatory signaling, and survival-versus-death decisions.
That matters because macrophages are front-line immune cells. They help detect danger, respond to infection, clear debris, and regulate inflammation. LPS acts like a bacterial alarm signal. SARS-CoV-2 spike protein is a viral-spike immune challenge. When RF exposure changed how these cells responded to those signals, the study moved the discussion beyond the outdated question of whether wireless radiation simply heats tissue. The better question is now: can chronic wireless exposure alter immune-cell behavior when the body is already under biological stress?
One of the most important findings was that RF exposure appeared to affect the mode of cell death. The study summary reports that apoptosis — the cleaner, more controlled form of programmed cell death — decreased or remained unchanged, while necrosis increased in cells treated with SARS-CoV-2 spike protein, LPS, or both for 48 hours under RF-involved conditions. Necrosis is a messier form of cell death that can spill cellular contents and intensify inflammatory signaling. That makes this finding directly relevant to the concept of immune dysregulation.
The paper also reported altered lysosomal and mitochondrial behavior. Lysosomes are the cell’s recycling and cleanup system. Mitochondria are energy-producing organelles and immune-signaling hubs. Mitochondria–lysosome crosstalk is now recognized as a major part of cellular stress regulation, metabolism, autophagy, and disease biology.
This is exactly the kind of evidence FDA should be required to evaluate under Public Law 90-602. The old thermal-only model asks whether RF radiation heats tissue. But this study asks a more modern biological question: what happens when low-level RF exposure intersects with immune stress, viral-spike signaling, bacterial inflammatory triggers, mitochondrial function, lysosomal function, nitric oxide, and inflammatory cell death?
That is not a fringe question. It is now a published cellular immunology question.
And it fits directly into the FDA confirmation debate. The next FDA Commissioner should be asked whether FDA will evaluate non-thermal RF biological effects, including immune-cell signaling, oxidative stress, mitochondrial dysfunction, lysosomal function, calcium-channel biology, reproductive endpoints, cancer endpoints, and chronic cumulative exposure. The FCC cannot answer those questions. The FCC is a spectrum regulator. HHS/FDA is where Congress placed electronic-product radiation health responsibility.
This new 2026 study does not need to prove that Wi‑Fi causes COVID complications in humans to matter. Its importance is more specific and more immediate: it shows that Wi‑Fi-frequency RF exposure can alter immune-cell responses to infection-related biological stressors in a non-heating experimental setting.
That is enough to demand oversight.
That is enough to demand FDA review.
That is enough to demand that senators stop letting wireless radiation safety be treated as somebody else’s problem.
